Alan List - Apr 26, 2022 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role
Chief Medical Officer
Signature
/s/ Dario Scimeca, Attorney-in-Fact for Alan List
Stock symbol
DTIL
Transactions as of
Apr 26, 2022
Transactions value $
-$16,328
Form type
4
Date filed
4/28/2022, 05:22 PM
Previous filing
Mar 7, 2022
Next filing
Jan 24, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DTIL Common Stock Options Exercise +26K 26K Apr 26, 2022 Direct F1, F2
transaction DTIL Common Stock Sale -$16.3K -7.78K -29.86% $2.10 18.3K Apr 27, 2022 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DTIL Restricted Stock Units Options Exercise $0 -26K -33.34% $0.00 52.1K Apr 26, 2022 Common Stock 26K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on April 26, 2022.
F2 Each RSU represents a contingent right to receive one share of the Company's Common Stock.
F3 The sale was effected pursuant to a Rule 10b5-1 plan. The transaction was a sell-to-cover exercise, with shares sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
F4 On June 7, 2021 the Reporting person was granted RSUs, which vest in three substantially equal annual installments beginning on April 26, 2022, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.

Remarks:

Exhibit List: Exhibit 24 Power of Attorney